Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Horizon Therapeutics Public Limited Company

HZNP•NASDAQ
Healthcare
Drug Manufacturers - General
$116.30
$0.00(0.00%)
U.S. Market opens in 12h 2m

Horizon Therapeutics Public Limited Company (HZNP) Stock Overview

Explore Horizon Therapeutics Public Limited Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap26.6B
P/E Ratio51.10
EPS (TTM)$1.88
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$166.21

HZNP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Horizon Therapeutics Public Limited Company (HZNP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $166.21.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 51.10 and a market capitalization of 26.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
18.47%
5-Year Change
225.86%
All-Time (Max) Change
1171.04%

Contact Information

https://www.horizontherapeutics.com
353 1 772 2100
70 St. Stephen’s Green, Dublin, NaN, 2

Company Facts

21,900 Employees
IPO DateJul 28, 2011
CountryIE

Frequently Asked Questions